Allegro’s Karageozian (OIS@AAO 2016)

Allegro OphthalmicsПодробнее

Allegro Ophthalmics: First-in-Class Anti-Integrin Agent (OIS@ASRS 2016)Подробнее

Allegro Ophthalmics - OIS@AAO 2015Подробнее

Allegro Ophthalmics - Innovation Showcase at Ophthalmology Innovation Summit @ AAO 2019Подробнее

Allegro Plans for Phase III of LuminateПодробнее

On-Sight Interview with Vicken Karageozian, MD, President & CEO, Allegro at OIS@AAO 2019Подробнее

Ophthalmology Innovator Stories: What Is Allegro Ophthalmics?Подробнее

Allegro’s Luminate Achieves Primary Endpoint in DME Trial (OIS@AAO 2016)Подробнее

Allegro Ophthalmics Reports Phase II Data for LuminateПодробнее

Allegro Ophthalmics - Innovation Showcase at Ophthalmology Innovation Summit @ ASCRS 2019Подробнее

Allegro ventures into the anterior segmentПодробнее

Sonata in Re Magg. Op 94 "Andante"Подробнее

jCyte Developing Cell-based RP Treatment at Ophthalmology Innovation Summit @ AAOПодробнее

Symphony in D Major: I. Overture: Allegro vivoПодробнее

Aldeyra Therapeutics - Innovation Showcase at Ophthalmology Innovation Summit @ AAO 2019Подробнее

Allegro Ophthalmics Preps for Phase III of RisuteganibПодробнее

Allegro Ophthalmics - Innovation Showcase at Ophthalmology Innovation Summit @ ASRS 2019Подробнее

For unto us a child is born ( Georg Friederich Haendel )Подробнее